Omega-3 may slash psychotic disorder risk: Study
Supplements of omega-3-rich fish oil may reduce the likelihood of developing psychotic disorders in high-risk people, say results of a new clinical trial.
Archives for February 2, 2010
Industry defends CAMs against “biased, poorly written” study
Industry has slammed a study in the Journal of the American College of Cardiology that highlighted dangers of cardiovascular disease patients using herbal products and called for drug-like laws to apply to the herbal sector.
ARS researchers track down antioxidants in oats
Scientists at the Agricultural Research Service (ARS) of the USDA have identified factors that influence the antioxidant content of oats.
Soy firms coordinate Haiti donations
A multinational alliance called SoyFoods Haiti Alliance Relief Effort, or SHARE is coordinating donation and delivery of protein-rich foods to the Haiti earthquake relief effort.
GSK company appeals vitamin D/calcium dosage restrictions
GlaxoSmithKline-owned German firm, Abtei Pharma Vertriebs, wants the European Food Safety Authority (EFSA) to reconsider its summer 2009 opinion that dose levels could not be established for a calcium/vitamin D bone health claim.
Vitamin B6 may affect heart disease risk: Study
Low levels of vitamin B6 may increase the risk of inflammation and metabolic conditions, and subsequently cardiovascular disease risk, says a new study.
Australian authorities investigating Hydroxycut
Australia’s Therapeutic Goods Administration (TGA) is reviewing the status of the weight loss product, Hydroxycut, which has been linked to liver problems.
US military may ‘shock and awe’ omega-3 market
A multi-million dollar omega-3 market could open up within two-to-three years if the US Department of Defense (DOD) orders its troops to take EPA and DHA omega 3 fatty acids.